miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3

  • Authors:
    • Chun-Guang Fan
    • Chun-Mei Wang
    • Chuan Tian
    • Yan Wang
    • Li Li
    • Wen-Sheng Sun
    • Rui-Feng Li
    • Yu-Gang Liu
  • View Affiliations

  • Published online on: July 1, 2011     https://doi.org/10.3892/or.2011.1375
  • Pages: 1281-1286
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

microRNAs (miRNAs) are short, non-coding RNAs with post-transcriptional regulatory functions that participate in diverse biological pathways. miR-122, a liver-specific miRNA, has been found to be down-regulated in hepatocellular carcinoma (HCC) and HCC-derived cell lines. In this study, miR-122 was down-regulated in the hepatitis B virus (HBV)-related HCC cell line HepG2.2.15 compared to HepG2. NDRG3, a member of the N-myc downstream-regulated gene (NDRG) family, was up-regulated in HepG2.2.15 and was identified as a target gene of miR-122. An inverse correlation between the expression of miR-122 and the NDRG3 protein was noted in HBV-related HCC specimens. The transfection of the miR-122 expression vector into the HepG2.2.15 cell line repressed the transcription and expression of NDRG3, which subsequently reversed the malignant phenotype of the cells. The replication of HBV, expression of viral antigens and proliferation of cells were significantly inhibited by restoration of miR-122. The data demonstrate that miR-122 plays an important role in HBV-related hepatocarcinogenesis by targeting NDRG3. Thus, miR-122 and NDRG3 represent key diagnostic markers and potential therapeutic targets for HBV-related HCC.

Related Articles

Journal Cover

November 2011
Volume 26 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fan C, Wang C, Tian C, Wang Y, Li L, Sun W, Li R and Liu Y: miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Oncol Rep 26: 1281-1286, 2011.
APA
Fan, C., Wang, C., Tian, C., Wang, Y., Li, L., Sun, W. ... Liu, Y. (2011). miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Oncology Reports, 26, 1281-1286. https://doi.org/10.3892/or.2011.1375
MLA
Fan, C., Wang, C., Tian, C., Wang, Y., Li, L., Sun, W., Li, R., Liu, Y."miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3". Oncology Reports 26.5 (2011): 1281-1286.
Chicago
Fan, C., Wang, C., Tian, C., Wang, Y., Li, L., Sun, W., Li, R., Liu, Y."miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3". Oncology Reports 26, no. 5 (2011): 1281-1286. https://doi.org/10.3892/or.2011.1375